Rare diseases
Investigational molecules
Locations
Study Comparing Enfortumab Vedotin and Pembrolizumab with Chemotherapy for Patients with Muscle-Invasive Bladder Cancer
FranceStudy of Pembrolizumab, Trastuzumab, and Chemotherapy for Patients with HER2 Positive Advanced Stomach or Gastroesophageal Junction Cancer
FranceStudy of NMS-03592088 for Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML)
FranceStudy on the Effectiveness and Safety of Ocrelizumab, Methylprednisolone, and Diphenhydramine Hydrochloride in Patients with Multiple Sclerosis
FranceStudy of Adagrasib Dosing in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation
FranceStudy Comparing SGN-B6A and Docetaxel for Adults with Previously Treated Non-Small Cell Lung Cancer
FranceStudy on Brentuximab Vedotin and Drug Combination for Patients with Peripheral T-cell Lymphoma with Less Than 10% CD30 Expression
FranceStudy on the Safety and Effects of BAY 2599023 (Peboctocogene Camaparvovec) for Adults with Severe Hemophilia A
FranceStudy of JDQ443 and Ribociclib in Combination for Adult Patients with Advanced Solid Tumors with KRAS G12C Mutation
FranceStudy on Frexalimab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients Aged 12-21 on Insulin Therapy
FranceStudy on RZ358 for Treating Congenital Hyperinsulinism in Patients
FranceStudy on Long-Term Safety of Atogepant for Preventing Migraine in Patients with Chronic or Episodic Migraine
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
